Truqap is usually a kinase inhibitor that actually works by blocking pathways that assist the most cancers cells endure and develop, so decreases cancer growth. Truqap is from a category of medicines known as an AKT inhibitor. Truqap acquired FDA approval on November 17, 2023, following constructive effects within the https://martinv221oal5.nytechwiki.com/user